Work

Updated recommendations for diagnosis and treatment of multiple myeloma in Switzerland

Year: 2025

Type: article

Abstract: Multiple myeloma is a malignant disease characterised by the clonal proliferation of plasma cells. Since the last update of the Swiss recommendations for the diagnosis and treatment of multiple myeloma in 2019, the therapeutic landscape has evolved significantly, with the development of new monoclonal antibodies, novel combination therapies, and the introduction of T-cell-redirecting treatments such as bispecific antibodies and CAR T-cell therapy. This article summarises the current diagnostic procedures and therapeutic recommendations in Switzerland.

Source: Swiss Medical Weekly

DOI: 10.57187/s.4252

Authors: Martina Bertschinger, Holger W. Auner, Veronika Ballova, Carmen De Ramon Ortiz, Christoph Driessen, Sabine Gerull, Dominik Heim, Barbara Jeker, Erika Lerch, Rouven Müller, Thomas Pabst, Panagiotis Samaras, Adrian Schmidt, Christian Taverna, Thilo Zander, Ulrich Mey, Christoph Renner

Institutions: Kantonsspital Winterthur, Centre Hospitalier Universitaire Vaudois, Kantonsspital Baden, University Hospital of Geneva, Kantonsspital St. Gallen, Kantonsspital Aarau, University Hospital of Basel, University Hospital of Bern, Ente Ospedaliero Cantonale, Ospedale San Giovanni Bellinzona, Istituto Oncologico della Svizzera Italiana, University Hospital Zurich, Triemli Hospital, Kantonsspital Münsterlingen, Luzerner Kantonsspital, Kantonsspital Graubünden, Klinik Hirslanden, GastroZentrum Hirslanden Zürich

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4415483629

FWCI:

Cites:

Cited by:

Related to: